FierceBiotech

FDA widens approval of Roche cobas HPV test to new sample media

The FDA approved Roche’s cobas HPV test for first-line screening of cervical cancer in women 25 and older using cervical specimens collected in SurePath preservative fluid, commonly used in Pap tests.
SiliconANGLE

SurePath AI launches Discovery service to enhance enterprise generative AI oversight

Generative artificial intelligence governance startup SurePath AI Inc. today announced the launch of SurePath AI Discovery, a new offering that provides rapid visibility into employee use of public AI ...
Nasdaq

BD Onclarity™ HPV Assay Receives FDA Approval for Use with Both BD SurePath™ Liquid-based Pap Test and Hologic ThinPrep® Pap Test

FRANKLIN LAKES, N.J., Feb. 21, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) ...
SiliconANGLE

SurePath AI raises $5.2M to advance generative AI governance platform

Generative artificial intelligence governance startup SurePath AI Inc. announced today that it has raised $5.2 million in funding to accelerate growth and enhance its platform for securely governing ...
Reuters

FDA approves first HPV test with SurePath preservative fluid

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...